CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 4,385 enrolled
Drug / intervention
Any Fixed Combination Therapydrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01637246
NCT01637246N/ACompleted

A Study of Patients With Primary Open Angle Glaucoma or Ocular Hypertension Who Were Insufficiently Responsive to Monotherapy

Allergan·observational·Posted Jul 11, 2012·Updated Sep 21, 2012

In Brief

An observational study evaluating Any Fixed Combination Therapy for Glaucoma, Open-Angle and Ocular Hypertension. Completed, enrolled 4,385 participants across 1 site.

Detailed Summary

This is a retrospective chart review and will assess changes in IOP after treatment with any fixed combination in patients who previously received monotherapy.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
200920102011201220132014201520162017201820192020202120222023202420252026
First PostedJul 11, 2012
Enrollment StartApr 1, 2009
Primary CompletionNov 1, 2011
TodayJul 2, 2026
Enrollment to primary: 2.6 yearsPosted 14.0 years ago

Interventions

Any Fixed Combination Therapydrug

Patients with POAG or OHT previously treated with monotherapy and currently treated with any fixed combination therapy. This was a retrospective chart review study, so no treatment was administered in this study.